CD274 and metastatic melanoma: In a recent study, Chen et al. discovered PD-L1 is packaged in the lumen of exosomes, and the levels of PD-L1 in exosomes played a crucial role in dictating the treatment response of anti-PD-1 antibody pembrolizumab immunotherapy in patients diagnosed with metastatic melanoma (34).